EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

On-Resin DIAMSAR-Conjugated CD38-Targeted Peptides and Their Inverso and Dimeric-Inverso Analogs for PET Imaging of Multiple Myeloma

Amit Kumar Sharma, Rui Tang iD, Alexander Zheleznyak, Brad Manion, Erin Teubner, Julie L Prior, Tommy Bauer, Michael Riley Dyer iD, Stephen Lees, Kimberly Kelly, Monica Shokeen iD

Bioconjugate Chemistry · 2026

DOI: 10.1021/acs.bioconjchem.5c00577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2026. Verfasst von Amit Kumar Sharma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States. Hauptthemen laut MEDLINE: ADP-ribosyl Cyclase 1, Multiple Myeloma, Peptides, Positron-Emission Tomography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD38 is an established biomarker of multiple myeloma (MM), and peptide-based radiopharmaceuticals targeted to this receptor offer a route to molecularly specific imaging. In this work, we identified a novel CD38-targeted peptide sequence (HAPWFRGGGGS) through phage display and synthesized it using automated solid-phase peptide synthesis. The peptide was modified by introducing a PEG4 spacer and on-resin conjugation of the DIAMSAR chelator, which forms a stable complex with Copper-64 (Cu-64), yielding DIAMSAR-PEG4-HAPWFRGGGGS (Monomer_L). [64Cu]Cu-Monomer_L was radiolabeled with high molar activity (>98% yield, ∼65 MBq/nmol) but showed suboptimal serum stability (∼45% intact at 2 h). To improve in vivo stability, the l-amino acid sequence was replaced with d-amino acid (Monomer_D), resulting in >90% serum stability and enhanced binding affinity toward CD38, as demonstrated by molecular docking and cell-binding assays in CD38-expressing MOLP2 human MM cells. To further increase avidity, a dimeric analog (Dimer_D) was designed by linking two Monomer_D units via a PEG4 linker. In viable MOLP2 MM cells, tracer uptake ranked as [64Cu]Cu-Dimer_D > [64Cu]Cu-Monomer_D > [64Cu]Cu-Monomer_L, and was markedly reduced by excess unlabeled peptide, confirming CD38-specific binding. Binding specificity and functional engagement of CD38 were further supported by antibody-blocking, enzymatic activity inhibition, and cellular internalization studies. Replacement of L-with d-amino acids improved binding affinity, lowering the Kd from 1043 nM ([64Cu]Cu-Monomer_L) to ∼740 nM ([64Cu]Cu-Monomer_D). The dimerization further lowered the Kd (∼730 nM) with markedly higher Bmax (6993 fmol/mg vs 3024 fmol/mg), consistent with avidity-driven enhancement in receptor engagement. In vivo small animal dynamic PET/CT and ex vivo biodistribution were performed in disseminated and subcutaneous MOLP2-CBR-GFP MM models with naïve controls. Uptake increased with peptide valency, showing maximum femoral uptake of 1.52 ± 0.35 and 2.93 ± 0.68% ID/mL for [64Cu]Cu-Monomer_D and [64Cu]Cu-Dimer_D, respectively, whereas naïve mice exhibited

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADP-ribosyl Cyclase 1Multiple MyelomaPeptidesPositron-Emission TomographyMembrane GlycoproteinsRadiopharmaceuticalsHumansAnimalsCopper RadioisotopesMiceCell Line, TumorTissue Distribution

Substanzen

ADP-ribosyl Cyclase 1PeptidesCopper RadioisotopesMembrane GlycoproteinsRadiopharmaceuticalsCD38 protein, humanCopper-64

Autor:innen und Institutionen

  • Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
  • Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia 22908, United States.
  • Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
  • Alvin J. Siteman Cancer Center, Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, Missouri 63110, United States.
  • Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri 63130, United States.

ORCID-Profile: Rui Tang, Michael Riley Dyer, Monica Shokeen

Förderung

  • NIH HHS
  • NCI NIH HHS
  • NCRR NIH HHS
  • National Cancer Institute
  • NIH Office of the Director

Zitieren

APA

Sharma, A. K., Tang, R., Zheleznyak, A., Manion, B., Teubner, E., Prior, J. L., Bauer, T., Dyer, M. R., Lees, S., Kelly, K., & Shokeen, M. (2026). On-Resin DIAMSAR-Conjugated CD38-Targeted Peptides and Their Inverso and Dimeric-Inverso Analogs for PET Imaging of Multiple Myeloma. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.5c00577

Vancouver

Sharma AK, Tang R, Zheleznyak A, Manion B, Teubner E, Prior JL, et al. On-Resin DIAMSAR-Conjugated CD38-Targeted Peptides and Their Inverso and Dimeric-Inverso Analogs for PET Imaging of Multiple Myeloma. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.5c00577

BibTeX
@article{Sharma2026,
  author = {Sharma, Amit Kumar and Tang, Rui and Zheleznyak, Alexander and Manion, Brad and Teubner, Erin and Prior, Julie L and Bauer, Tommy and Dyer, Michael Riley and Lees, Stephen and Kelly, Kimberly and Shokeen, Monica},
  title = {On-Resin DIAMSAR-Conjugated CD38-Targeted Peptides and Their Inverso and Dimeric-Inverso Analogs for PET Imaging of Multiple Myeloma},
  journal = {Bioconjugate Chemistry},
  year = {2026},
  doi = {10.1021/acs.bioconjchem.5c00577}
}
Kostenlos starten →